Biorestorative Therapies, INC. (BRTX) SEC Filings — 2025
16 SEC filings for Biorestorative Therapies, INC. (BRTX) in 2025.
Filings
- BioRestorative Files S-1 for 508K Share Resale; No Proceeds to Company — S-1 · Nov 18, 2025
- BioRestorative Therapies Reports Q3 2025 Financials — 8-K · Nov 12, 2025
- BioRestorative Therapies' Net Loss Widens Amid Soaring R&D Costs — 10-Q · Nov 12, 2025
- BioRestorative Therapies Files 8-K: Material Agreement & Equity Sales — 8-K · Oct 8, 2025
- BioRestorative Therapies Holds Annual Meeting Vote — 8-K · Sep 25, 2025
- BioRestorative Therapies 8-K Filing — 8-K · Aug 14, 2025
- BioRestorative Therapies Files Q2 2025 8-K — 8-K · Aug 12, 2025
- BRTX Narrows Q2 Loss Amidst Zero Revenue, High Burn Rate — 10-Q · Aug 12, 2025
- BioRestorative Therapies Details Executive Equity Compensation — DEF 14A · Aug 8, 2025
- Biorestorative Therapies, INC. 8-K Filing — 8-K · Jun 13, 2025
- BioRestorative Therapies Q1 2025 Update — 8-K · May 14, 2025
- BioRestorative Therapies Files Q1 2025 10-Q — 10-Q · May 14, 2025
- BioRestorative Therapies Changes Accountants — 8-K · Apr 21, 2025
- BioRestorative Therapies Files 2024 10-K — 10-K · Mar 28, 2025
- BioRestorative Therapies Reports 2024 Financials — 8-K · Mar 27, 2025
- BioRestorative Therapies Files 8-K — 8-K · Feb 10, 2025